Cargando…

Identification of key candidate tumor biomarkers in non-small-cell lung cancer by in silico analysis

Lung cancer is a common malignancy worldwide. The aim of the present study was to investigate differentially expressed genes (DEGs) between non-small-cell lung cancer (NSCLC) and normal lung tissue, and to reveal the potential molecular mechanism underlying NSCLC. The Gene Expression Omnibus databas...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Weiping, Zhu, Song, Zhang, Yifei, Xiao, Jinghua, Tian, Dongbo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2020
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6924182/ https://www.ncbi.nlm.nih.gov/pubmed/31897214 http://dx.doi.org/10.3892/ol.2019.11169

Ejemplares similares

Identification of Key Biomarkers and Candidate Molecules in Non-Small-Cell Lung Cancer by Integrated Bioinformatics Analysis
por: Yu, Liyan, et al.
Publicado: (2023)

In silico identification of drug candidates against COVID-19
por: Wu, Yifei, et al.
Publicado: (2020)

Identification of serum MiRNAs as candidate biomarkers for non-small cell lung cancer diagnosis
por: Zhang, Xintong, et al.
Publicado: (2022)

Key Candidate Prognostic Biomarkers Correlated with Immune Infiltration in Hepatocellular Carcinoma
por: Deng, Zenghua, et al.
Publicado: (2021)

Identification and Integrated Analysis of Key Biomarkers for Diagnosis and Prognosis of Non-Small Cell Lung Cancer
por: Liu, Xingyuan, et al.
Publicado: (2019)

Identification of novel biomarkers and candidate small molecule drugs in non-small-cell lung cancer by integrated microarray analysis
por: Wu, Qiong, et al.
Publicado: (2019)

Identification of Candidate Biomarkers Correlated With the Pathogenesis and Prognosis of Non-small Cell Lung Cancer via Integrated Bioinformatics Analysis
por: Ni, Mengwei, et al.
Publicado: (2018)

Identification of Candidate Vaccine Antigens In Silico
por: Flower, Darren R., et al.
Publicado: (2012)

Identification of tumor-educated platelet biomarkers of non-small-cell lung cancer
por: Sheng, Meiling, et al.
Publicado: (2018)

In-Silico Prediction of Key Metabolic Differences between Two Non-Small Cell Lung Cancer Subtypes
por: Rezola, Alberto, et al.
Publicado: (2014)

miR-183-5p regulates ECM and EMT to promote non-small cell lung cancer progression by targeting LOXL4
por: Chen, Jinghua, et al.
Publicado: (2023)

Identification of Key Biomarkers and Pathways in Small-Cell Lung Cancer Using Biological Analysis
por: Liu, Huanqing, et al.
Publicado: (2021)

Bioinformatics analysis reveals 6 key biomarkers associated with non-small-cell lung cancer
por: Dai, Bai, et al.
Publicado: (2019)

Identification and validation of candidate epigenetic biomarkers in lung adenocarcinoma
por: Daugaard, Iben, et al.
Publicado: (2016)

Identification and Integrate Analysis of Key Biomarkers for Diagnosis and Prognosis of Non-Small Cell Lung Cancer Based on Bioinformatics Analysis
por: Gong, Ke, et al.
Publicado: (2021)

In silico identification of potential key regulatory factors in smoking-induced lung cancer
por: El-aarag, Salem A., et al.
Publicado: (2017)

Serum thrombospondin-2 is a candidate diagnosis biomarker for early non-small-cell lung cancer
por: Jiang, Yi-ming, et al.
Publicado: (2019)

Serum IL‐35 levels is a new candidate biomarker of cancer‐related cachexia in stage IV non‐small cell lung cancer
por: Li, Zengxun, et al.
Publicado: (2022)

Identification of potential biomarkers and candidate small molecule drugs in glioblastoma
por: Lu, Wei-cheng, et al.
Publicado: (2020)

Identification of exosome protein panels as predictive biomarkers for non-small cell lung cancer
por: Luo, Bin, et al.
Publicado: (2023)

Identification of key genes in non-small cell lung cancer by bioinformatics analysis
por: Zhang, Li, et al.
Publicado: (2019)

A computational method for the identification of candidate drugs for non-small cell lung cancer
por: Chen, Lei, et al.
Publicado: (2017)

Identification of key differentially expressed genes associated with non-small cell lung cancer by bioinformatics analyses
por: Xiao, Yubo, et al.
Publicado: (2018)

Chaperonin (HSP60) and annexin-2 are candidate biomarkers for non-small cell lung carcinoma
por: Ağababaoğlu, İsmail, et al.
Publicado: (2017)

PRKCDBP Methylation is a Potential and Promising Candidate Biomarker for Non-small Cell Lung Cancer
por: LI, Jing, et al.
Publicado: (2022)

Discovery of a Potent Candidate for RET-Specific Non-Small-Cell Lung Cancer—A Combined In Silico and In Vitro Strategy
por: Ramesh, Priyanka, et al.
Publicado: (2021)

Identification of Novel Prognostic Biomarkers Relevant to Immune Infiltration in Lung Adenocarcinoma
por: Xia, Zhi, et al.
Publicado: (2022)

Identification of key candidate genes and small molecule drugs in cervical cancer by bioinformatics strategy
por: Tang, Xin, et al.
Publicado: (2018)

Tumor‐derived exosomal proteins as diagnostic biomarkers in non‐small cell lung cancer
por: Niu, Limin, et al.
Publicado: (2018)

Identification of Key Genes and FUNCTIONAL Pathway in Radioresistance of Non-Small Cell Lung Cancer
por: Li, Shouying, et al.
Publicado: (2022)

Identification of key biomarkers and potential molecular mechanisms in lung cancer by bioinformatics analysis
por: Li, Zhenhua, et al.
Publicado: (2019)

Chaperonin (HSP60) and annexin-2 are candidate biomarkers for non-small cell lung carcinoma: Erratum
Publicado: (2017)

In silico identification of novel biomarkers for key players in transition from normal colon tissue to adenomatous polyps
por: Isik, Zerrin, et al.
Publicado: (2022)

Identification of key candidate genes associated with prognosis of lung adenocarcinoma by integrated bioinformatical analysis
por: Li, Jinghang, et al.
Publicado: (2020)

An in silico approach to identify early damage biomarker candidates in metachromatic leukodystrophy
por: Gómez, Jessica, et al.
Publicado: (2023)

Key regulators of apoptosis execution as biomarker candidates in melanoma
por: Charles, Emilie M, et al.
Publicado: (2014)

Application of Circulating Tumor DNA as a Biomarker for Non-Small Cell Lung Cancer
por: Yang, Jialiang, et al.
Publicado: (2021)

Tumor-Derived Exosomal miRNAs as Diagnostic Biomarkers in Non-Small Cell Lung Cancer
por: Zhang, Zhijun, et al.
Publicado: (2020)

Identification of Potential Key Genes and Prognostic Biomarkers of Lung Cancer Based on Bioinformatics
por: Cai, Kaier, et al.
Publicado: (2023)

Identification and validation of the methylation biomarkers of non-small cell lung cancer (NSCLC)
por: Guo, Shicheng, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_vmav1bvf9usn02g1mn4312v3mu